Physician profile
Ryan L Cooley
NPI 1255308813
$16,459.73
in general payments reported to CMS, 2019-2025
19 companies · $2,555 in 2025
The $2,555 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,779 · 2020: $180 · 2021: $6,426 · 2022: $2,738 · 2023: $2,586 · 2024: $196 · 2025: $2,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102 · Travel and Lodging: $2,035 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.77 |
| Travel and Lodging | $2,035.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,880.81 | 2021-2025 | Micra, Adapta, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $3,394.36 | 2022-2025 | Acticor 7 Vr-T Dx |
| Medtronic Vascular, INC. | $1,526.81 | 2019-2020 | |
| Cvrx, INC. | $1,409.57 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $979.38 | 2021-2025 | Aveir |
| Boston Scientific Corporation | $931.47 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, General - Pain Management |
| Biosense Webster, INC. | $646.09 | 2019-2025 | Qdot Micro, Carto 3, Octaray Mapping Catheter |
| Novartis Pharmaceuticals Corporation | $167.82 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $134.74 | 2020-2022 | |
| Tactile Systems Technology INC | $85.33 | 2021 | |
| Atricure, INC. | $80.32 | 2019-2021 | |
| Cardiofocus, INC. | $72.15 | 2020 | |
| Pfizer INC. | $68.21 | 2020-2021 | |
| Cardiva Medical, INC. | $29.25 | 2023 | Cardiva Vascade 6/7f Vcs |
| E.R. Squibb & Sons, L.L.C. | $15.18 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.60 | 2021 | |
| Alnylam Pharmaceuticals INC. | $13.22 | 2022 | |
| Merck Sharp & Dohme LLC | $11.42 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Cooley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.